Nur77 modulator 5
Nur77 modulator 5 is a Nur77 modulator. Nur77 modulator 5 induces lysosomal dysfunction, impaired autophagic flux, and apoptosis with increased PARP cleavage, TUNEL positivity, and Annexin V/PI staining. Nur77 modulator 5 can be used for the research of gastric cancer.
For research use only. We do not sell to patients.
- CAS No.: 3068830-45-2
- Formula: C21H18Cl2N4O2S
- Molecular Weight:461.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Nuclear Hormone Receptor 4A/NR4A Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Nur77/NR4A1 |
In Vitro
Nur77 modulator 5 (Compound 6K) binds directly to the Nur77 ligand-binding domain with an equilibrium dissociation constant (KD) of 0.62 μM, forming stable hydrogen bonds, π-π stacking, and hydrophobic interactions with key residues in the binding pocket[1].
Nur77 modulator 5 (48 h) potently inhibits the growth of multiple human cancer cell lines (most potently HGC-27 gastric cancer cells with an IC50 of 0.53 μM) and exhibits minimal cytotoxicity toward normal GES-1 gastric epithelial cells (IC50 = 24.33 μM)[1].
Nur77 modulator 5 (24-48 h) reduces viability of HGC-27 and AGS gastric cancer cells in a time-dependent manner, with greater potency against HGC-27 cells (IC50 = 1.51 μM) than AGS cells (IC50 = 3.40 μM)[1].
Nur77 modulator 5 (2.5-5 μM; ~2 weeks) inhibits clonogenic survival of HGC-27 and AGS gastric cancer cells in a concentration-dependent manner, with more pronounced effects in HGC-27 cells[1].
Nur77 modulator 5 (4 μM; 5 h) induces prominent cytoplasmic vacuolization in HGC-27 and AGS gastric cancer cells[1].
Nur77 modulator 5 (1.25-5 μM; 24 h) induces apoptosis in HGC-27 gastric cancer cells[1].
Nur77 modulator 5 (0.625-4 μM; 5 h-2 weeks) induces lysosomal dysfunction and impaired autophagic flux in HGC-27 gastric cancer cells, as evidenced by increased LC3-II/p62 levels, reduced Lyso-Tracker fluorescence, and attenuation of vacuolization and growth inhibition by Bafilomycin A1 (HY-100558)[1].
Nur77 modulator 5 (0.625-4 μM; 12 h-2 weeks) reduces Nur77 protein levels in HGC-27 gastric cancer cells in a dose-dependent manner, and Nur77 overexpression attenuates Nur77 modulator 5-induced lysosomal dysfunction, apoptotic signaling, and growth inhibition[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human gastric cancer cell lines (HGC-27, AGS)
-
Concentration:2.5 μM; 5 μM
-
Incubation Time:~2 weeks
-
Result:Reduced both the size and number of colonies in a concentration-dependent manner.
Caused significant reductions in colony number in HGC-27 cells.
Caused a significant reduction in colony number in AGS cells at 5 μM.
-
Cell Line:human gastric cancer cell line (HGC-27)
-
Concentration:1.25 μM; 2.5 μM; 4 μM; 5 μM
-
Incubation Time:24 h
-
Result:Enhanced PARP cleavage in a dose-dependent manner.
Increased the number of TUNEL-positive cells.
Elevated the percentage of apoptotic cells in a dose-dependent manner, as measured by Annexin V/PI staining.
-
Cell Line:human gastric cancer cell line (HGC-27)
-
Concentration:0.625 μM; 1.25 μM; 2.5 μM
-
Incubation Time:24 h
-
Result:Increased LC3-II and p62 levels in a dose-dependent manner.
-
Cell Line:Nur77-overexpressing human gastric cancer cell line (HGC-27)
-
Concentration:0.625 μM; 1.25 μM; 2.5 μM; 4 μM
-
Incubation Time:12 h; 24 h
-
Result:Reduced Nur77 protein levels in a dose-dependent manner.
Restored CTSB, LAMP2, LC3, p62, and cleaved PARP, and partially restored clonogenic growth when Nur77 was overexpressed.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (male, 16-20 g at purchase, subcutaneous xenograft via HGC-27 cell injection to form a xenograft model)[1]
-
Dosage:20 mg/kg
-
Administration:i.p.; once every 3 days; 24 days
-
Result:Markedly inhibited tumor growth, with endpoint tumor volumes significantly lower than the vehicle control.
Significantly reduced endpoint tumor weights compared to the vehicle control.
Elevated levels of Nur77, CTSB, p62, and LC3 in tumor tissues via immunohistochemistry.
Showed no significant histopathological changes in major organs (heart, liver, spleen, lung, kidney) via hematoxylin and eosin staining.
Chemical Information
-
CAS No. 3068830-45-2
-
Molecular Weight 461.36
-
Formula C21H18Cl2N4O2S
-
SMILES
COC1=CC=C(C=C1)C2=CC=C(C(C)=N2)C(NNC(NC3=CC=C(C(Cl)=C3)Cl)=S)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)